By Ehrlich Group / March 7, 2019 / Uncategorized

By: Dr. Jacob Blumenthal and Maier Fenster, Ehrlich & Fenster of Ehrlich Group. A few days ago I received an e-mail from one of our clients saying ” Dear Jacob, we are about to present our clinical study results in two weeks from today. Will that affect our intellectual property protection?”. Of course it will. Many …

By Ehrlich Group / February 17, 2019 / Uncategorized

By Adv. Yehuda Neubauer, Partner, Ehrlich, Neubauer & Melzer of Ehrlich Group. In Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc. dated January 22, 2019, The United States Supreme Court unanimously held that the sale of an invention to a party that is obligated to keep the invention confidential may be considered “on sale” for the …

By Ehrlich Group / October 19, 2018 / Uncategorized

The Israel Patent Office recently published its 2017 Annual Report, which reflects the state of IP prosecution in Israel regarding the submission and examination of patent, trademark and design applications. The report reveals interesting trends and changes in the IP registration system in Israel.